Tropicana Slim merupakan salah satu brand yang terkenal dengan produk-produk rendah gula, dan varian Nutty Chocolate ...

Shares of Merck & Co. were headed higher in early Thursday trading, after the drugmaker extended its long streak of quarterly earnings beats and held firm with its full-year outlook despite ...

Spanyol, VIVA – Kuaci menjadi makanan favorit penonton sepakbola di stadion-stadion Spanyol. Akan tetapi, kini ada klub yang melarang kuaci untuk masuk ke tribun karena dianggap malah membuat banyak ...

Jakarta (ANTARA) - Klub divisi kedua Liga Spanyol, Elche, melarang penjualan dan konsumsi kuaci di kandang mereka, Stadion Manuel Martinez Valero. Elche Club de Futbol telah memutuskan untuk melarang ...

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

Thousands of jobs could be on the horizon for American workers as drug manufacturer Merck takes steps to move manufacturing into the U.S., particularly in the form of a $1 billion state-of-the-art ...

She regularly appears on CBS News 24/7 to discuss her reporting. Merck is investing $1 billion to build a U.S. plant in Delaware, in a show of its commitment to domestic manufacturing. The move ...

(Reuters) -U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Donald Trump's tariffs.

About two months after receiving a sizable taxpayer-funded grant, Merck & Co. officially announced it would build its newest manufacturing facility near Elsmere. A groundbreaking ceremony was held ...

Merck (NYSE:MRK) operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The 52-week range of Merck stock price was $75.93 to $134.63.

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around $3.9 billion, expanding its portfolio of rare disease and cancer ...